Back

The Algerian Group 'Saïdal' Signs Agreement with German 'Boehringer Ingelheim' to Localize Innovative Medicines

June 8, 2026AL24 | الاقتصادal24news.dz
The Algerian Group 'Saïdal' Signs Agreement with German 'Boehringer Ingelheim' to Localize Innovative Medicines

The Algerian pharmaceutical industrial group 'Saïdal' signed a cooperation agreement today, Monday, with the leading German company in the research and development of biopharmaceuticals 'Boehringer Ingelheim', aimed at localizing the manufacturing and production of an innovative treatment for pulmonary fibrosis in Algeria. The signing ceremony was overseen by the Minister of Pharmaceutical Industry, Wassim Gouidri, and the Ambassador of the Federal Republic of Germany to Algeria, George Felsheim, at the production unit of the Saïdal group in El Harrach, Algiers.

Share on social media

Related Articles

Mr. Rakash presents investment opportunities in Algeria to the national community in Switzerland

Mr. Rakash presents investment opportunities in Algeria to the national community in Switzerland

Algeria - The Director General of the Algerian Investment Promotion Agency, Omar Rakash, presented in Geneva (Switzerland) the investment opportunities offered by the Algerian economy during an information day dedicated to introducing the business climate in Algeria and attracting investors from the national community residing in Switzerland, as stated today, Wednesday, in a statement from the agency.

Nov 11, 2026aps.dz

News Disclaimer: Articles are curated from third-party sources for informational purposes. We do not verify or endorse the accuracy of third-party content.